November 6, 2024
Acceptable Consequences? What Providers and Patients Need to Know Before Taking the “Opill”
Nava Health’s Associate Medical Director, Dr. Angela DeRosa, shares a groundbreaking editorial.
In this comprehensive piece, Dr. Angela DeRosa, an expert in integrative and preventative medicine, examines the broader implications of increased access to progestin-only OTC oral contraceptives.
“One should ask, “Why is it OK to induce testosterone deficiency in women, but NOT in men?”
Read the full editorial here.